Cite
Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma.
MLA
Yuan, Xiao-Han, et al. “Association between EGFR/KRAS Mutation and Expression of VEGFA, VEGFR and VEGFR2 in Lung Adenocarcinoma.” Oncology Letters, vol. 16, no. 2, Aug. 2018, pp. 2105–12. EBSCOhost, https://doi.org/10.3892/ol.2018.8901.
APA
Yuan, X.-H., Yang, J., Wang, X.-Y., Zhang, X.-L., Qin, T.-T., & Li, K. (2018). Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma. Oncology Letters, 16(2), 2105–2112. https://doi.org/10.3892/ol.2018.8901
Chicago
Yuan, Xiao-Han, Jie Yang, Xin-Yue Wang, Xiao-Ling Zhang, Ting-Ting Qin, and Kai Li. 2018. “Association between EGFR/KRAS Mutation and Expression of VEGFA, VEGFR and VEGFR2 in Lung Adenocarcinoma.” Oncology Letters 16 (2): 2105–12. doi:10.3892/ol.2018.8901.